Crescendo was founded by Sam Roosz and Michael Glassman to enable better health outcomes for patients, while protecting the interests of research participants. This means bringing world-leading technologies in data security to clinical research and ensuring that every member of the Crescendo team feels proud to have our products deployed as part of future care for our loved ones. As a public benefit corporation, our corporate structure enables decisions that prioritize societal impact. We’re here to enable research that is far more accessible to patients and clinicians, so that the costs of new research fall precipitously, and there are pathways to efficiently monitor the long-term safety and efficacy of new treatments.